Alimentiv

About Alimentiv

Alimentiv is a specialized gastrointestinal clinical research organization (CRO) located in downtown London on Dundas Street. The company provides full-service clinical trial management and research solutions specifically for the gastrointestinal field, serving sponsors and global partners who are developing treatments for GI diseases. The business offers comprehensive clinical trial services including development strategy, protocol development, clinical project management, and medical monitoring. Their technical offerings feature medical imaging solutions such as central reading for endoscopy, AI-powered endoscopy, and noninvasive modalities like intestinal ultrasound (IUS) and magnetic resonance enterography (MRE). Additionally, they provide laboratory and biomarker services through their specialty histopathology lab, AcelaBio, which handles tissue analysis, spatial biology, and bioinformatics. Their consulting services cover regulatory strategy, clinical data science, medical writing, and advanced biostatistics. Alimentiv traces its roots back to 1986 as Robarts Clinical Trials, founded by Dr. Henry Barnett. Under the leadership of Dr. Brian Feagan starting in 1997, the organization shifted its focus toward gastrointestinal research. It became independently owned in 2014 and underwent a rebranding to Alimentiv in 2020. The company is now part of Alimentiv Health Trust and has expanded its reach to include a network of over 5,000 sites in more than 60 countries. They describe their approach as being driven by a commitment to improving the lives of people with gastrointestinal disorders, emphasizing a 100-year view of research resilience.